In compliance with current regulations, let us know which audience you belong to:
Espansione Group's new leadership team's story of cross-generational exchange gets discussed closely in this interview featuring Matteo Corbellino, the Group's Chief Marketing & Innovation Officer and Rodolfo Pomar, the company's retiring founder.
In the article both the strategy for global business expansion and future vision for the company's growth are discussed.
Quoting directly from the article:
"The coming months will see us engaged on several fronts," explains Corbellino, “the strategic levers on which we intend to focus are the digitization of the company as a whole, its repositioning on the market through the rebranding process kicked-off in 2022, the development of our commercial capabilities through the launch of several collaborations, the expansion into new geographies and, of course, innovation—which remains one of the distinguishing features."
And, going further:
"When we structured the plan for inter-generational exchange with the guys,” Pomar reveals, "my ambition was to see Espansione continue to be the research and development hub it’s always been—always striving for progress. What we needed was a team who had the ambition of doing good to people as much at heart as we did, one who could develop our technologies further with the same passion we had.”
Read the full article by downloading the .pdf below.
Access the original article on Harvard Business Review at this link [Language: Italian]
About Espansione Group
Espansione Group is a pioneer in the medtech industry, on a mission to develop and market innovative, non-invasive solutions for prevention and management of conditions in ophthalmology and beyond.
The company’s certified medical solutions leverage proprietary technologies such as Light Modulation™ Low-level Light Therapy (LM™ LLLT) photobiomodulation (PBM), with an ambition to redefine standards of care by expanding on their applications, with a constant commitment to science, research and development, and customer excellence.
Strategic partnerships with the industry, a strong commitment to scientific excellence and a will to shape the future have enabled Espansione Group’s advanced medical technologies to be present in over 50 countries, serving thousands healthcare providers worldwide.
For more information, visit www.espansionegroup.it
Espansione Group Press Office
press@espansione.it
© 2023 Espansione Group, All Rights Reserved
Posted on January 13th, 2022 in Newsroom